Literature DB >> 18219559

Key parameters affecting the initial leaky effect of hemoglobin-loaded nanoparticles as blood substitutes.

Xiaolan Zhang1, Changsheng Liu, Yuan Yuan, Shiyu Zhang, Xiaoqian Shan, Yan Sheng, Feng Xu.   

Abstract

In order to realize long-term carrying/delivering oxygen and minimize the adverse effects of free hemoglobin (Hb) in vivo, Hb is desired to be confined in Hb-loaded nanoparticles (HbP), a novel blood substitute with potential clinical applications, and thus functions as the native red blood cells (RBCs). However, the initial burst release of Hb ("leaky effect") greatly underscores the significance of this work. The study described here wants to disclose the key preparative parameters, including polymer, excipients in the inner aqueous phase and solvent profile, affecting the Hb release behavior (the initial 24 h) from HbP fabricated by commonly used solvent diffusion/evaporation double emulsion technique. The results demonstrate that PEGlytated polymers, regardless of two- or tri-block copolymers show slower release compared with the corresponding non-PEGlytated ones. The higher polymer concentration yields lower initial release. PEG200, added as excipient facilitates Hb burst effect to about 38.4%, almost 17% increase compared to the control ( approximately 21%), whereas, PVA and Poloxamer188, due to amphiphilic nature, can effectively attenuate this leakage to about 13.0 and 5.1%, respectively. The diffusion/extraction rate from oil phase and the subsequent evaporation rate from the aqueous continuous phase of solvents impose different influences on Hb release. To reduce the burst effect, the initial diffusion/extraction rate should be slow, whereas, the concomitant evaporation rate should be as fast as possible. The results obtained here will be guidance's for the future tailored design of more desirable polymersome nanoparticle blood substitutes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219559     DOI: 10.1007/s10856-007-3358-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  29 in total

Review 1.  Blood substitutes.

Authors:  R M Winslow
Journal:  Adv Drug Deliv Rev       Date:  2000-02-28       Impact factor: 15.470

2.  Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.

Authors:  Juan Wang; Barbara M Wang; Steven P Schwendeman
Journal:  Biomaterials       Date:  2004-05       Impact factor: 12.479

3.  How porosity and size affect the drug release mechanisms from PLGA-based microparticles.

Authors:  D Klose; F Siepmann; K Elkharraz; S Krenzlin; J Siepmann
Journal:  Int J Pharm       Date:  2006-02-28       Impact factor: 5.875

4.  Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles.

Authors:  Xiaosong Luan; Marc Skupin; Jürgen Siepmann; Roland Bodmeier
Journal:  Int J Pharm       Date:  2006-06-09       Impact factor: 5.875

5.  Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.

Authors:  A K Bajpai; Smitha Bhanu
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

6.  Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions.

Authors:  R Lee; K Neya; T A Svizzero; G J Vlahakes
Journal:  J Appl Physiol (1985)       Date:  1995-07

7.  PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers.

Authors:  Y P Li; Y Y Pei; Z H Zhou; X Y Zhang; Z H Gu; J Ding; J J Zhou; X J Gao
Journal:  J Control Release       Date:  2001-04-28       Impact factor: 9.776

8.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

9.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic.

Authors:  Valentina Coccoli; Alessia Luciani; Silvia Orsi; Vincenzo Guarino; Filippo Causa; Paolo Antonio Netti
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

View more
  2 in total

1.  A noninvasive method for measuring the oxygen binding-releasing capacity of hemoglobin-loaded polymeric nanoparticles as oxygen carrier.

Authors:  Xiaolan Zhang; Changsheng Liu; Yuan Yuan; Xiaoqian Shan; Yan Sheng; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2009-02-08       Impact factor: 3.896

2.  In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.

Authors:  Yan Sheng; Yuan Yuan; Changsheng Liu; Xinyi Tao; Xiaoqian Shan; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2009-04-14       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.